Noticias de BCDA_US

Noticias del mercado

Últimas noticias sobre BCDA_US — 258 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: BCDA_US ✕ 258 resultados
21/05/2026 BCDA_US — Investing.com ES ← EN
El director ejecutivo de BioCardia, Peter Altman, compra acciones de la empresa por valor de 1.570 dólares

BioCardia CEO Peter Altman buys $1,570 in company stock

21/05/2026 BCDA_US — Minichart
BioCardia Announces Positive CardiAMP Chronic Myocardial Ischemia Trial Results with Reduced Angina at EuroPCR 2026
21/05/2026 BCDA_US — Investing.com ES ← EN
BioCardia informa resultados positivos del ensayo CardiAMP CMI

BioCardia reports positive results from CardiAMP CMI trial

21/05/2026 BCDA_US — Investing.com
BioCardia reports positive results from CardiAMP CMI trial By Investing.com
21/05/2026 BCDA_US — Investing.com India
BioCardia reports positive results from CardiAMP CMI trial
21/05/2026 BCDA_US — Investing.com
BioCardia reports positive results from CardiAMP CMI trial By Investing.com
21/05/2026 BCDA_US — Investing.com
BioCardia reports positive results from CardiAMP CMI trial By Investing.com
21/05/2026 BCDA_US — Investing.com
BioCardia reports positive results from CardiAMP CMI trial
21/05/2026 BCDA_US — Stock Titan
BioCardia (NASDAQ: BCDA) CEO adds 1,700 shares in May open‑market buys
21/05/2026 BCDA_US — Stock Titan
BioCardia (NASDAQ: BCDA) posts CardiAMP CMI data with durable angina and exercise gains
21/05/2026 BCDA_US — The Manila Times
BioCardia Announces CardiAMP Chronic Myocardial Ischemia Trial Results Presented at EuroPCR Showed Durable Improvements in Exercise Tolerance with Reduced Angina Frequency
21/05/2026 BCDA_US — Investing.com
BioCardia CEO Peter Altman buys $1,570 in company stock
21/05/2026 BCDA_US — Stock Titan
Heart cell therapy linked to longer walks, 82% fewer angina attacks
21/05/2026 BCDA_US — Investing.com
BioCardia reports positive results from CardiAMP CMI trial By Investing.com
21/05/2026 BCDA_US — Investing.com UK
BioCardia reports positive results from CardiAMP CMI trial By Investing.com
21/05/2026 BCDA_US — Investing.com UK
BioCardia CEO Peter Altman buys $1,570 in company stock By Investing.com
20/05/2026 BCDA_US — MSN ES ← EN
BioCardia describe la presentación de la Shonin japonesa en ~7 meses y apunta a un plazo de ~19 meses para la aprobación de CardiAMP

BioCardia outlines Japan Shonin filing in ~7 months and targets ~19-month path to approval for CardiAMP

19/05/2026 BCDA_US — Insider Monkey
BioCardia, Inc. (NASDAQ:BCDA) Q1 2026 Earnings Call Transcript

Operador: Damas y caballeros, gracias por estar atentos. Buenas tardes y bienvenidos a la conferencia telefónica sobre actualización comercial y resultados financieros del primer trimestre de BioCardia 2026.

19/05/2026 BCDA_US — The Manila Times ES ← EN
BioCardia participará en una charla informal en la exhibición de empresas de atención médica de Alliance Global Partners (AGP)

SUNNYVALE, California, 19 de mayo de 2026 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], líder mundial en terapias celulares y derivadas de células para el tratamiento de enfermedades cardiovasculares...

19/05/2026 BCDA_US — Stock Titan
Watch BioCardia’s virtual fireside chat at A.G.P. healthcare showcase

Página 4 de 13

keyboard_arrow_up